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Background and purpose — Although the pathogenesis of osteo-
arthritis (OA) is not well understood, chondrocyte-mediated 
infl ammatory responses (triggered by the activation of innate 
immune receptors by damage-associated molecules) are thought 
to be involved. We examined the relationship between Toll-like 
receptors (TLRs) and OA in cartilage from 2 joints differing in 
size and mechanical loading: the fi rst carpometacarpal (CMC-I) 
and the knee. 
Patients and methods — Samples of human cartilage obtained 
from OA CMC-I and knee joints were immunostained for TLRs 
(1–9) and analyzed using histomorphometry and principal com-
ponent analysis (PCA). mRNA expression levels were analyzed 
with RT-PCR. Collected synovial fl uid (SF) samples were screened 
for the presence of soluble forms of TLR2 and TLR4 by enzyme-
linked immunosorbent assay (ELISA).
Results — In contrast to knee OA, TLR expression in CMC-I 
OA did not show grade-dependent overall profi le changes, but 
PCA revealed that TLR expression profi les clustered according to 
their cellular compartment organization. Protein levels of TLR4 
were substantially higher in knee OA than in CMC-I OA, while 
the opposite was the case at the mRNA level. ELISA assays con-
fi rmed the presence of soluble forms of TLR2 and TLR4 in SF, 
with sTLR4 being considerably higher in CMC-I OA than in knee 
OA. 
Interpretation — We observed that TLRs are differentially 
expressed in OA cartilage, depending on the joint. Soluble forms 
of TLR2 and TLR4 were detected for the fi rst time in SF of osteo-
arthritic joints, with soluble TLR4 being differentially expressed. 
Together, our results suggest that negative regulatory mecha-
nisms of innate immunity may be involved in the pathomolecular 
mechanisms of osteoarthritis.
■
Osteoarthritis (OA) is the most common joint disease. It 
affects large, weight-bearing joints such as the knees and hips, 
and also non-weight-bearing joints such as those in the hands.
OA is considered to be a disease of the hyaline cartilage, 
with disturbed degradation and degeneration of this cartilage 
mainly occurring because of wear-and-tear injuries caused 
by mechanical loading of the joint and subsequent infl amma-
tory host responses (Konttinen et al. 2012). However, we still 
barely understand how these pathomechanisms lead to patho-
physiological conditions and how are they regulated. 
Cartilage degradation, a hallmark of OA, is also a conse-
quence of a compromised ability of resident chondrocytes to 
maintain tissue homeostasis. Interestingly, OA joint homeo-
stasis is in part mediated by activation of the innate immune 
system, which is currently viewed as an intrinsic part of the 
infl ammatory cycle of OA (Scanzello et al. 2008, Liu-Bryan 
2013). The critical point about the innate immune system’s 
role in OA lies in the reaction to the biological, physiologi-
cal, and mechanical changes in the joint over time. In con-
trast to the adaptive immune system, innate immunity plays 
a pivotal role in the host defense against microbial agents, 
and also in modulation of tissue homoeostasis by recognizing 
distinct pathogen- and damage-associated molecular patterns 
(PAMPs) and DAMPs by pattern recognition receptors (PRRs) 
such as Toll-like receptors (TLRs) and NOD-like receptors 
(NLRs) (Chen and Nunez 2010). Cartilage degradation prod-
ucts derived either from traumatic injuries or cartilage degen-
eration may therefore act as DAMPs and consequently acti-
vate the local reaction of the innate immune system (Gomez et 
al. 2015). Innate immune activation of infl ammatory pathways 
may induce signaling cascades in chondrocytes, which lead to 
the upregulation of cartilage matrix-degrading proteases such 
as MMP-1, MMP-3, MMP-13, and ADAMTS aggrecanases 
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while also downregulating aggrecan and collagen type II, a 
pattern generally seen in the chondrocytic phenotype of OA 
(Sokolove and Lepus 2013). 
All members of the TLR family are present in OA cartilage 
chondrocytes from knee joints (Sillat et al. 2013). However, 
the pathogenesis of OA may be inherently different in differ-
ent anatomic joints—given the evidence from epidemiology, 
from genetic and epigenetic studies, and on the impact of risk 
factors (van Saase et al. 1989, Xu et al. 2012, den Hollander 
et al. 2014, Thijssen et al. 2015). This led us to the hypothesis 
that the pathogenesis of primary OA, and innate immunity, 
may vary depending on the location of the joint. We therefore 
wanted to determine whether smaller joints, such as the fi rst 
carpometacarpal (CMC-I), have similar knee OA TLR-profi le 
phenotypes. Insight into TLRs, important molecular players in 
OA, in these 2 different joints might help us to better compre-
hend joint-specifi c pathomolecular mechanisms in OA.
Patients and methods 
Patient samples
Osteochondral cylinder samples (from 11 women and 4 men) 
were harvested from tibial plateaus obtained from total knee 
replacements (TKAs) due to severe knee OA. The mean age of 
the patients was 67 (52–87) years. These samples were graded 
for disease severity using the OARSI grading (Pritzker et al. 
2006).
The mean age of the patients subjected to trapeziectomy, 
due to severe CMC-I OA, was 58 (43–80) years. All patients 
had been treated with non-steroidal anti-infl ammatory drugs 
and a thumb spica splint, without pain relief or functional 
improvement. Severity of the CMC-I OA was assessed using 
the Eaton-Glickel grading (Eaton and Glickel 1987) (Supple-
mentary Figure 1). All patients had non-erosive OA of the 
CMC-I, confi rmed by radiological features (Verbruggen and 
Veys 1996, Altman and Gold 2007). OARSI grading could not 
be performed for CMC-I cartilage samples because trapezi-
ectomy was sometimes only partial, leading to a non-uniform 
sampling zone, which is essential for OARSI grading. Thus, 
instead we used the radiological Eaton-Glickel scale to evalu-
ate the disease severity of the CMC-I OA (Eaton and Glickel 
1987). Radiographs of hand OA correlate positively with the 
histological assessment of cartilage in post-mortem samples 
(Sunk et al. 2013). It is therefore clear that both scales refl ected 
the severity (i.e. grade) of OA.
The arthritic trapezium bone was excised completely (trape-
ziectomy) or partially, depending on the presence of OA in the 
scaphotrapezial joint. None of the patients had Eaton-Glickel 
grade-I OA, which is a contraindication for arthroplasty. 
Healthy control cartilage-subchondral bone samples were 
obtained from the unaffected CMC-III joint, resected from 
patients undergoing total wrist arthrodesis for posttraumatic 
OA of the wrist. This joint was included in the wrist fusion 
to enable plate fi xation from the third metacarpal bone to the 
distal radius. The healthy controls were from 2 men (aged 45 
and 53 years). The samples were fi xed in neutral-buffered 10% 
formalin, decalcifi ed in 10% EDTA, pH 7.4, and processed in 
paraffi n. All patients undergoing TKA or trapeziectomy were 
randomly selected. 
Collection of synovial fl uid samples
Patients with knee meniscectomy, knee OA, or CMC-I OA 
were randomly selected for collection of synovial fl uid (SF) 
samples via needle aspiration before opening the joint.
 Knee OA SF samples were requested from Biobanco-iMM, 
Lisbon Academic Medical Center, Lisbon, Portugal. Blood-
contaminated SF samples were excluded. SF maintained at 
4°C within a 2-hour window was aliquoted into sterile Eppen-
dorf tubes, centrifuged at 1,200 g for 5 min at room tempera-
ture to separate solid debris and cells from the fl uid phase, 
snap frozen in liquid nitrogen, and stored at −80°C. When 
fi rst thawed, SF was treated with a protease inhibitor cocktail 
(Roche Diagnostics, Meylan, France). Epidemiological data 
regarding the patients are given in Table 1. Selection criteria 
are described in more detail in Supplementary material.
Immunohistochemistry
Articular cartilage samples from CMC-I, CMC-III and knee 
OA were stained immunohistochemically for TLR1–9, using 
the avidin-biotin peroxidase method. Briefl y, 4-µm tissue 
sections from CMC-I, knee OA, and CMC-III samples were 
deparaffi nized and rehydrated. Antigen retrieval was done in 
10 mM citrate buffer, pH 6.0, for 1 h at 70°C. Endogenous per-
oxidase was quenched in 0.3% H2O2. Sections were blocked 
with normal goat serum and then incubated (1) overnight at 
4°C in 2 µg/mL TLR1 IgG, 1.1 µg/mL TLR2 IgG, 2 µg/mL 
TLR3 IgG, 1.3 µg/mL TLR4 IgG, 1.3 µg/mL TLR5 IgG, 1 µg/
mL TLR6 IgG, 0.8 µg/mL TLR7 IgG, 1 µg/mL TLR8 IgG, 
1 µg/mL TLR9 IgG, and 1.6 µg/mL TLR10 IgG (rabbit anti-
human antibodies; Santa Cruz Biotechnology, Santa Cruz, 
CA), (2) in biotinylated goat anti-rabbit IgG (Vectorlabs, Bur-
lingame, CA), and (3) in avidin-biotin-peroxidase complex. 
Color was developed using H2O2 and 3,3’-diaminobenzidine 
for 10 min, followed by counterstaining with Mayer hematox-
ylin. Incubations were performed at 22°C, with PBS washes 
Table 1. Epidemiological data for patients with healthy knees, knee 
osteoarthritis (OA) patients, and fi rst carpometacarpal (CMC-I) OA 
patients
 Healthy knee Knee OA a CMC-I OA
n 10 10 10
Age a, mean (range) 63 (25–84) 64 (52–87) 60 (43–80)
Sex, men/women 4/6 4/6 3/7
BMI b, mean (SD) 27 (4.4) 28 (3.5) 25 (3.3)
a, b Age and BMI were not statistically signifi cantly different between 
the groups studied.
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in-between the steps unless otherwise stated. The samples 
on slides were dehydrated, cleared, and mounted. Knee OA 
samples were used as positive controls. For negative staining 
controls, non-immune IgG was used instead of—and at the 
same concentration as—the primary specifi c antibodies.
Microscopy and histomorphometry
Stained samples were evaluated microscopically. For histo-
morphometric calculations, the percentages of TLR-positive 
cells were evaluated from 5 high-power fi elds (magnifi cation 
200×) from each area of interest.
Real-time polymerase chain reaction
Total RNA was isolated from equivalent-graded frozen car-
tilage samples from CMC-I patients (n = 10) and knee OA 
patients (n = 10) using the RNAqueous kit (Life Technologies) 
and following the manufacturer’s protocol. Relative quantifi -
cation of the gene levels was performed by comparing the Ct 
values of the TLR4 gene, correcting for TATA-binding protein 
(TBP) content (ΔCt). Relative expression levels are given. 
The mRNA was extracted from frozen cartilage samples 
since formalin-fi xed, paraffi n-embedded (FFPE) samples are 
prone to mRNA degradation.
ELISA
SF was measured for soluble TLR2 and soluble TLR4 mol-
ecules using specifi c sandwich enzyme-linked immunosor-
bent assay (ELISA) (Uscn Life Science, Hubei, PRC). Assays 
were performed according to the manufacturer’s instructions. 
Samples were run in duplicate and absorbance was measured 
at 450 nm. 
Statistics
Differences between groups were tested using the non-para-
metric Mann-Whitney-Wilcoxon test or the non-parametric 
Kruskal-Wallis test, as appropriate. Principal component anal-
yses (PCA) allows easy overview of a large dataset by reduc-
ing the dimensionality of the data while retaining the variation 
present in the original dataset. Despite being used initially 
and primarily in large populations of patients, PCA has simi-
lar noise-reducing properties in small populations. The Eigen 
value 1 criterion was used to select the appropriate number 
of principal components (PCs), i.e. PCs with Eigenvalue > 
1. Loading values vary from −1 to 1 and are interpreted as 
the degree of variable correlation within each PC. Missing 
data cases were excluded list-wise. Both oblique promax and 
orthogonal varimax rotations were examined, and produced 
similar results. PCA was performed using SPSS version 22.0 
software. All the other statistical analyses were performed 
using this software.
Ethics and funding
The study protocol was accepted by the local ethics committee 
(Dnro_59/13/03/02/2013).
This work was supported by ORTON Orthopaedic Hospital 
of the Invalid Foundation, Finska Läkaresällskapet, HUS Evo 
grants, the Sigrid Jusélius Foundation, and the Maire Lisko 
Foundation. The funding sponsors had no other role in the cur-
rent study.
Results
Immunohistochemistry
Our immunohistochemistry results confi rmed the expres-
sion of several TLRs in cartilage from different CMC-I OA 
grades, which was in line with the observed expression in car-
tilage from knee OA (Figure 1). 
However, histomorphometric analysis revealed that TLRs 
followed distinctive and rather heterogeneous expression pat-
terns, in contrast to the homogenous expression patterns of 
TLRs in knee OA cartilage (Figure 2A; TLR expression data 
from knee not shown).
PCA was performed on CMC-I histomorphometric data to 
assess the relationships of individual TLR variables across the 
entire dataset. PC1 and PC2 disclosed 2 clusters separated by 
95% confi dence ellipsoids, 1 cluster being composed of TLRs 
1–3, TLR5, and TLR6, while the other was composed of TLRs 
7–9. PC1 and PC2 represented 76% of the data (56% and 
21%, respectively). TLR4 was unequivocally separated from 
clusters and correlated negatively with the higher expression 
of all the other TLRs (Figure 2B).
Real-time polymerase chain reaction
In contrast to protein levels of TLR 4, the relative levels of 
expression of TLR4 mRNA were higher in CMC-I OA carti-
lage than in knee OA cartilage (Figure 3).
ELISA
Given the different mRNA and protein expression levels of 
TLR4 in CMC-I and knee OA joints, we hypothesized that 
such differences might be explained, in part, by solubilization 
of TLR4 protein. sTLR4 ELISA analysis of SF obtained from 
both joints revealed that sTLR4 forms were present, and in 
signifi cantly different concentrations (Figure 4).
Solubilization of TLR2 (the only other TLR that is known to 
be soluble) was also analyzed. We detected similar, small con-
centrations of sTLR2 in the different arthritic groups (Figure 
4).
Discussion
We have shown here for the fi rst time that TLR expression in 
OA cartilage follows expression patterns that are dependent 
on the joint affected. This suggests that the pathophysiological 
mechanisms regulating OA may differ according to joint type. 
Our fi ndings show that healthy chondrocytes resident in carti-
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lage from CMC-I and knee joints have a limited expression of 
TLRs, in accordance with earlier reports on TLR2 and TLR4 
(Kim et al. 2006). However, as the depth of progression of OA 
increases through cartilage (OARSI grade defi nition), TLR 
expression follows different patterns depending of the type of 
joint. In knee OA, we observed an analogous increase in TLR 
expression as the severity increased, in line with a recent study 
from our group (Barreto et al. 2013). On the other hand, in 
CMC-I OA, TLR expression was heterogeneous and patient-
dependent. Given the heterogeneous CMC-I histomorphomet-
ric data, we used PCA in order to determine whether protein-
specifi c expression patterns were present. PCA revealed a 
clear clustering of TLRs that can form heterodimeric com-
plexes at the surface of the cell (TLR1, 2, 5, and 6), in parallel 
with the clustering of the endosomal TLRs (TLR7, 8, and 9). 
In general, all these MyD88-dependent TLRs co-operate with 
each other (O’Neill et al. 2013). Secondly, TLR3 clustered 
together with the cell surface TLRs. Unlike the previously 
mentioned TLRs, TLR3 exclusively uses a TRIF-dependent 
signaling pathway. The association of TLR3 with TLR2 might 
have functional consequences, given their synergistic proin-
fl ammatory effects that mediate a “2-hit” trigger (Vanhoutte et 
al. 2008). TLR4 is the only TLR to use both MyD88 and TRIF 
signaling, and our results have shown that it is unequivocally 
distinct from other TLRs. Notably, TLR4 protein expression 
remained consistently low in all CMC-I samples, in striking 
contrast to the high degree of expression in knee OA samples. 
The reasons for the observed difference in TLR expression 
in CMC-I and knee OA joints may relate to the common and 
specifi c factors known to be associated with hand and knee 
Figure 1. TLR3 and TLR4 expression in cartilage from hand and knee OA joints. A–C. Eaton-Glickel grade-2 CMC-I OA 
stained for TLR3 and TLR4, together with a negative staining control (panel C). D–F. OARSI grade-2 knee OA stained for 
TLR3 and TLR4, together with a negative staining control (panel F). G–I, healthy control CMC-III stained for TLR3 and 
TLR4, together with a negative staining control (panel I). Magnifi cation: 100×.
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Figure 2. Histomorphometric and principal component analysis (PCA) of toll-like receptor protein expression in cartilage from CMC-I OA patients. 
A. TLR expression was heterogeneous with no statistical signifi cance during progression between stages. CMC-I OA cartilage degradation stages 
were graded according to the Eaton-Glickel radiological score. Results are expressed as mean and SD. For each SFA score, n = 4. B. PCA of the 
histomorphometric TLR data in OA of the CMC-I joint. 95% confi dence ellipsoids drawn from PCA show a clear separation of the TLR7, TLR8, 
and TLR9 cluster from the TLR1, TLR2, TLR3, and TLR5 cluster—and that TLR4 had no association with either. Loading values varied from −1 to 
1 and represent correlation of the variable with the principal components (PCs). Cases with missing data were excluded list-wise. Oblique promar 
and orthoganal varimax rotations gave similar results. C. The eigen value 1 criterion was used to select the PCs.
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Figure 3. Relative TLR4 mRNA expression in CMC-I and 
knee OA cartilage. The expression was markedly higher in 
CMC-I OA cartilage than in knee OA cartilage. The results 
are expressed as mean and SD. a p < 0.01 indicates sta-
tistically signifi cant differences between pairwise compari-
son groups using the Mann-Whitney test (non-parametric). 
Data were obtained from 10 patients with each OA joint 
type, and run in duplicate.
Figure 4. Scatter plot of synovial fl uid concentrations of sTLR2 and sTLR4 in 
different arthritic conditions. A. Synovial fl uid levels of sTLR2 were rather homog-
enous in healthy knee, knee OA, CMC-I OA patients. B. Synovial fl uid levels of 
sTLR4 were signifi cantly higher in CMC-I OA, followed by lower levels in knee 
OA and even lower levels in healthy knees. Each dot represents 1 sample. Mean 
values (± SD). SF samples were obtained from 10 patients in each group. b p 
< 0.005, c p < 0.001, indicating statistically signifi cant differences between pair-
wise comparisons using the Kruskal-Wallis test (non-parametric). 
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OA joints. Risk factors such as obesity, for example, may be 
involved. Obesity is known to double the likelihood of hand 
OA (Yusuf et al. 2010). However, given that hand OA occurs 
in a non-weight-bearing joint, obesity-related systemic factors 
other than mechanical overload—such as adipokines—may be 
involved (Berenbaum et al. 2013, Thijssen et al. 2015). Adipo-
kines are not only present systemically but are also present in 
OA joint SF at pathophysiological concentrations (Staikos et 
al. 2013). Adipokines have been shown to have anti- and pro-
infl ammatory properties but have also been found to regulate 
TLR expression and vice versa (Batra et al. 2007, Kopp et al. 
2009). In the present study, BMI levels were similar in both 
the CMC-I OA and knee OA patient groups (Table 1).
Genetic and epigenetic differences between the 2 joints may 
play an important role in activation of the innate immunity, 
and consequently TLR expression. Several risk-conferring 
loci for hip, knee, and hand OA have recently been identifi ed 
through genome-wide association study (GWAS) efforts. This 
information also showed that certain loci are associated with 
certain joints only, further highlighting the need for joint strat-
ifi cation when studying OA (Reynard and Loughlin. 2013, 
Styrkarsdottir et al. 2014). Moreover, a recent study demon-
strated that certain loci located in/near TGFA (transforming 
growth factor alpha) are associated with cartilage thickness in 
OA knee and hip joints (Castano-Betancourt et al. 2016). In 
the CMC-I joint, cartilage thickness is thinner than knee and 
hip cartilage; moreover, TGFA is known to have regulatory 
effects on TLR expression (Miller et al. 2005). Interestingly, 
TLR3 and TLR9 polymorphisms are associated with severe 
knee OA (Su et al. 2012, Yang et al. 2013). The association of 
TLR polymorphisms with other OA joints, such as hand OA, 
remains to be investigated.
Since the differences in the patterns of TLR4 protein expres-
sion might have arisen from regulation of gene expression, we 
examined the TLR4 mRNA levels in cartilage samples from 
CMC-I OA patients and knee OA patients. Surprisingly, TLR4 
mRNA levels were substantially higher in CMC-I OA than in 
knee OA. The fact that there was dysregulation in expression 
of TLR4 mRNA and TLR4 protein was an important fi nding. 
TLR4 is one of the main innate immune receptors; it recog-
nizes several endogenous ligands present in OA joints, such as 
fi bronectin and S100A8/A9 (Gomez et al. 2015).
Nevertheless, the current fi ndings lead us to believe that
CMC-I OA TLR4 protein expression was being downregu-
lated, possibly as an attempt to control TLR4. Interestingly, 
in acute renal injury—where the integrity of the extracellular 
matrix (ECM) is compromised—it was observed that increase 
in TLR4 mRNA was not preceded by an increase in TLR4 
protein expression. Instead, extracellular TLR4 was being 
released via a solubilization mechanism (Zager et al. 2007). 
This biological response occurs by soluble ligand-binding 
neutralization and/or decreased surface apical expression, pre-
venting further ligand binding to TLR4 at the cell membrane, 
and consequently activation of TLR4 signaling. Amniotic 
fl uid, saliva, blood, cerebrospinal fl uid, and kidney and liver 
are examples of body fl uids/organs where increased release 
of soluble TLR4 has been observed (Mitsuzawa et al. 2006, 
Zager et al. 2007, Kacerovsky et al. 2012, Uchimura et al. 
2014, Sokol et al. 2016). Interestingly, sTLR4 has also been 
proposed as a potential systemic biomarker for infl ammatory 
conditions, including rheumatoid arthritis (Ten Oever et al. 
2014). We hypothesized that such a mechanism might also 
occur in TLR-equipped tissues of the OA joints. In particular, 
increased solubilization of TLR4 in the CMC-I joint would 
explain the discrepancies between the mRNA and the protein 
data.
Indeed, we did detect sTLR4 forms in SF from knee and 
CMC-I arthritic joints, with statistically signifi cantly higher 
concentrations in SF from CMC-I OA than in SF from knee 
OA. Such differences in concentration levels might then 
explain the reduced TLR4 protein expression observed in 
cartilage from CMC-I OA joints. It is therefore possible to 
envision an increase in solubilization of sTLR4 (reducing 
surface protein expression) as a way of negatively regulating 
the known increase in the presence of TLR4-specifi c endog-
enous ligands in SF from OA and other infl ammatory arthri-
tis (van Lent et al. 2012, Nair et al. 2012). Similarly, others 
have reported increased concentrations of endogenous ligand 
MRP18/4 in plasma and reduced TLR4 expression (Rahman 
et al. 2014). The fact we detected soluble forms of TLR2 and 
TLR4, with the latter being differentially regulated, is further 
evidence of the importance of TLR4 in infl ammatory compo-
nents/mechanisms associated with OA, which shape the OA 
disease concept (Houard et al. 2013, Gomez et al. 2015).  Sur-
prisingly, sTLR4 allowed us to discriminate between healthy 
knee and knee OA, thus implicating sTLR4 as a potential can-
didate biomarker for OA studies. The mechanism by which 
such TLR4 solubilization occurs (alternative splicing and/or 
proteolytic cleavage) was not addressed in these experiments 
and it is still unclear how this occurs. 
In summary, epidemiological, genetic, and biomarker-
related associations between hand OA and other OA joints 
have been intensely studied, and associations have also been 
found. Even so, few studies have confi rmed that extensive 
common pathomechanisms occur in the different OA joints. 
Our fi ndings at this early stage confi rm the hypothesis that 
the expression of TLRs is inherently different in knee OA and 
CMC-I OA, particularly for TLR4, which would also suggest 
that major differences exist in the innate immunity mecha-
nisms that drive OA in different joints. Our results add an 
extra piece of evidence to the current literature stressing that 
the “disease process” of OA is unlikely to be uniform across 
all synovial joints of the body.
Supplementary material
Supplementary material is available in the online version of 
the article.
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